+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768260
  • Report
  • April 2019
  • Region: Global
  • 82 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Astellas Pharma Inc
  • BELLUS Health Inc
  • Celerion Inc
  • Merck & Co Inc
  • Pfizer Inc
  • MORE
The global clinical trial report- “2019 Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Interstitial Cystitis (Painful Bladder Syndrome). It presents in-depth analysis of Interstitial Cystitis (Painful Bladder Syndrome) clinical trials across markets and companies. The research work is for providing complete understanding into trends in Interstitial Cystitis (Painful Bladder Syndrome).

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Interstitial Cystitis (Painful Bladder Syndrome) clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Interstitial Cystitis (Painful Bladder Syndrome)

The research work is prepared through extensive and continuous research on Interstitial Cystitis (Painful Bladder Syndrome) trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Interstitial Cystitis (Painful Bladder Syndrome) patients are identified
  • The report includes panorama of Interstitial Cystitis (Painful Bladder Syndrome) clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Interstitial Cystitis (Painful Bladder Syndrome) clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Allergan Plc
  • Astellas Pharma Inc
  • BELLUS Health Inc
  • Celerion Inc
  • Merck & Co Inc
  • Pfizer Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Region
2.2.2 Average Enrollment of Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Interstitial Cystitis (Painful Bladder Syndrome) Treatment, 2019

3. Region wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials
3.1 Asia Pacific Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Country
3.2 Europe Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Country
3.3 North America Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Country
3.4 Middle East and Africa Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Country
3.5 South and Central America Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Country

4. Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trial Trends
4.1 Start Year wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials
4.2 Phase wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials
4.3 Trial Status wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials
4.4 Trial Type wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials

5. Interstitial Cystitis (Painful Bladder Syndrome) Average Enrollment Trends
5.1 Average Enrollment in Interstitial Cystitis (Painful Bladder Syndrome) Trials by Year
5.2 Average Enrollment in Interstitial Cystitis (Painful Bladder Syndrome) Trials by Phase
5.3 Average Enrollment in Interstitial Cystitis (Painful Bladder Syndrome) Trials by Status
5.4 Average Enrollment in Interstitial Cystitis (Painful Bladder Syndrome) Trials by Type of Trial

6. Companies Participating in Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials
6.1 Interstitial Cystitis (Painful Bladder Syndrome) Trials by Sponsor Type
6.2 Interstitial Cystitis (Painful Bladder Syndrome) Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Interstitial Cystitis (Painful Bladder Syndrome) Trials- Phase 1
7.2 Interstitial Cystitis (Painful Bladder Syndrome) Trials- Phase 2
7.3 Interstitial Cystitis (Painful Bladder Syndrome) Trials- Phase 3
7.4 Interstitial Cystitis (Painful Bladder Syndrome) Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials and Enrolment
Figure 5: Europe - Country wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials and Enrolment
Figure 7: North America - Country wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials and Enrolment
Figure 9: Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Phase
Figure 10: Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Trial Status
Figure 11: Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Type
Figure 12: Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Sponsor Type
Figure 13: Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials by Leading Sponsors
Figure 14: Interstitial Cystitis (Painful Bladder Syndrome) Average Enrollment by Phase
Figure 15: Interstitial Cystitis (Painful Bladder Syndrome) Average Enrollment by Trial Status
Figure 16: Interstitial Cystitis (Painful Bladder Syndrome) Average Enrollment by Type
Figure 17: Interstitial Cystitis (Painful Bladder Syndrome)- Average Enrolment by Type of Sponsors
Figure 18: Interstitial Cystitis (Painful Bladder Syndrome)- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials and Enrolment
Table 5: Europe - Country wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials and Enrolment
Table 7: North America - Country wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Interstitial Cystitis (Painful Bladder Syndrome) Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Interstitial Cystitis (Painful Bladder Syndrome) Average Enrollment by Phase
Table 15: Interstitial Cystitis (Painful Bladder Syndrome) Average Enrollment by Trial Status
Table 16: Interstitial Cystitis (Painful Bladder Syndrome) Average Enrollment by Type
Table 17: Interstitial Cystitis (Painful Bladder Syndrome)- Average Enrolment by Type of Sponsors
Table 18: Interstitial Cystitis (Painful Bladder Syndrome)- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Allergan Plc
  • Aquinox Pharmaceuticals Inc
  • Astellas Pharma Inc
  • BELLUS Health Inc
  • Celerion Inc
  • Lipella Pharmaceuticals Inc
  • Merck & Co Inc
  • Parexel International Corp
  • Pfizer Inc
  • Taris Biomedical LLC
Note: Product cover images may vary from those shown
Adroll
adroll